These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18791638)

  • 1. Modeling spinal muscular atrophy in Drosophila.
    Chang HC; Dimlich DN; Yokokura T; Mukherjee A; Kankel MW; Sen A; Sridhar V; Fulga TA; Hart AC; Van Vactor D; Artavanis-Tsakonas S
    PLoS One; 2008 Sep; 3(9):e3209. PubMed ID: 18791638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
    Kim JK; Caine C; Awano T; Herbst R; Monani UR
    Hum Mol Genet; 2017 Jul; 26(13):2377-2385. PubMed ID: 28379354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
    Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ
    J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular defects in a Drosophila survival motor neuron gene mutant.
    Chan YB; Miguel-Aliaga I; Franks C; Thomas N; Trülzsch B; Sattelle DB; Davies KE; van den Heuvel M
    Hum Mol Genet; 2003 Jun; 12(12):1367-76. PubMed ID: 12783845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO; De Repentigny Y; Tierney A; Beauvais A; Michaud J; Chehade L; Thabet M; Paul B; Reilly A; Gagnon S; Renaud JM; Kothary R
    EBioMedicine; 2020 May; 55():102750. PubMed ID: 32339936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
    Goulet BB; Kothary R; Parks RJ
    Curr Mol Med; 2013 Aug; 13(7):1160-74. PubMed ID: 23514457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
    Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
    Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling.
    Sen A; Yokokura T; Kankel MW; Dimlich DN; Manent J; Sanyal S; Artavanis-Tsakonas S
    J Cell Biol; 2011 Feb; 192(3):481-95. PubMed ID: 21300852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced P53 levels ameliorate neuromuscular junction loss without affecting motor neuron pathology in a mouse model of spinal muscular atrophy.
    Courtney NL; Mole AJ; Thomson AK; Murray LM
    Cell Death Dis; 2019 Jul; 10(7):515. PubMed ID: 31273192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
    Feng Z; Lam S; Tenn ES; Ghosh AS; Cantor S; Zhang W; Yen PF; Chen KS; Burden S; Paushkin S; Ayalon G; Ko CP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL; Chen TH; Hsu YY; Cheng YH; Juang BT; Jong YJ
    PLoS One; 2016; 11(4):e0154723. PubMed ID: 27124114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the therapeutic window in a severe animal model of spinal muscular atrophy.
    Robbins KL; Glascock JJ; Osman EY; Miller MR; Lorson CL
    Hum Mol Genet; 2014 Sep; 23(17):4559-68. PubMed ID: 24722206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
    Gavrilina TO; McGovern VL; Workman E; Crawford TO; Gogliotti RG; DiDonato CJ; Monani UR; Morris GE; Burghes AH
    Hum Mol Genet; 2008 Apr; 17(8):1063-75. PubMed ID: 18178576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV9-DOK7 gene therapy reduces disease severity in Smn
    Kaifer KA; Villalón E; Smith CE; Simon ME; Marquez J; Hopkins AE; Morcos TI; Lorson CL
    Biochem Biophys Res Commun; 2020 Sep; 530(1):107-114. PubMed ID: 32828271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.
    Kariya S; Park GH; Maeno-Hikichi Y; Leykekhman O; Lutz C; Arkovitz MS; Landmesser LT; Monani UR
    Hum Mol Genet; 2008 Aug; 17(16):2552-69. PubMed ID: 18492800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
    Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.
    Hosseinibarkooie S; Peters M; Torres-Benito L; Rastetter RH; Hupperich K; Hoffmann A; Mendoza-Ferreira N; Kaczmarek A; Janzen E; Milbradt J; Lamkemeyer T; Rigo F; Bennett CF; Guschlbauer C; Büschges A; Hammerschmidt M; Riessland M; Kye MJ; Clemen CS; Wirth B
    Am J Hum Genet; 2016 Sep; 99(3):647-665. PubMed ID: 27499521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMA-causing missense mutations in survival motor neuron (Smn) display a wide range of phenotypes when modeled in Drosophila.
    Praveen K; Wen Y; Gray KM; Noto JJ; Patlolla AR; Van Duyne GD; Matera AG
    PLoS Genet; 2014 Aug; 10(8):e1004489. PubMed ID: 25144193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.